Tuesday, October 1, 2013

Testosterone Therapy: Scant Evidence of Benefit in CVD Risk

Medscape Medical News
Steven Fox
Sep 25, 2013

Although there is some evidence that low endogenous testosterone levels may be linked to cardiovascular risk, a review of the last 43 years of literature finds scant definitive evidence that testosterone supplementation affects that risk.

Johannes B. Ruige, MD, PhD, from the Department of Endocrinology, Ghent University Hospital, Belgium, and colleagues. report their findings in an article published online September 24 in the Journal of Clinical Endocrinology & Metabolism.

Read the full Mescape Medical News report
(free sign-up may be required)